APA (7th ed.) Citation

Yao, Q., Nordfors, L., Axelsson, J., Heimbürger, O., Qureshi, A., Báràny, P., . . . Stenvinkel, P. (2005). Peroxisome proliferator-activated receptor γ polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy. Atherosclerosis (00219150), 182(1), 105. https://doi.org/10.1016/j.atherosclerosis.2005.01.033

Chicago Style (17th ed.) Citation

Yao, Q., et al. "Peroxisome Proliferator-activated Receptor γ Polymorphisms Affect Systemic Inflammation and Survival in End-stage Renal Disease Patients Starting Renal Replacement Therapy." Atherosclerosis (00219150) 182, no. 1 (2005): 105. https://doi.org/10.1016/j.atherosclerosis.2005.01.033.

MLA (9th ed.) Citation

Yao, Q., et al. "Peroxisome Proliferator-activated Receptor γ Polymorphisms Affect Systemic Inflammation and Survival in End-stage Renal Disease Patients Starting Renal Replacement Therapy." Atherosclerosis (00219150), vol. 182, no. 1, 2005, p. 105, https://doi.org/10.1016/j.atherosclerosis.2005.01.033.